ArticleProceedings of the National Academy of Sciences of the United States of America2008

Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist.

Ailsa J Frew et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.